JP2001512319A5 - - Google Patents

Download PDF

Info

Publication number
JP2001512319A5
JP2001512319A5 JP1998536013A JP53601398A JP2001512319A5 JP 2001512319 A5 JP2001512319 A5 JP 2001512319A5 JP 1998536013 A JP1998536013 A JP 1998536013A JP 53601398 A JP53601398 A JP 53601398A JP 2001512319 A5 JP2001512319 A5 JP 2001512319A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1998536013A
Other languages
English (en)
Japanese (ja)
Other versions
JP4560616B2 (ja
JP2001512319A (ja
Filing date
Publication date
Priority claimed from US08/802,322 external-priority patent/US5932425A/en
Application filed filed Critical
Publication of JP2001512319A publication Critical patent/JP2001512319A/ja
Publication of JP2001512319A5 publication Critical patent/JP2001512319A5/ja
Application granted granted Critical
Publication of JP4560616B2 publication Critical patent/JP4560616B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP53601398A 1997-02-18 1998-02-18 細胞のNF−κB活性化を調節するための組成物および方法 Expired - Fee Related JP4560616B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/802,322 US5932425A (en) 1997-02-18 1997-02-18 Compositions and methods for modulating cellular NF-κB activation
US08/802,322 1997-02-18
PCT/US1998/003163 WO1998036070A1 (en) 1997-02-18 1998-02-18 COMPOSITIONS AND METHODS FOR MODULATING CELLULAR NF-λB ACTIVATION

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2009255576A Division JP2010063461A (ja) 1997-02-18 2009-11-06 細胞のNF−κB活性化を調節するための組成物および方法

Publications (3)

Publication Number Publication Date
JP2001512319A JP2001512319A (ja) 2001-08-21
JP2001512319A5 true JP2001512319A5 (cg-RX-API-DMAC10.html) 2005-10-06
JP4560616B2 JP4560616B2 (ja) 2010-10-13

Family

ID=25183386

Family Applications (2)

Application Number Title Priority Date Filing Date
JP53601398A Expired - Fee Related JP4560616B2 (ja) 1997-02-18 1998-02-18 細胞のNF−κB活性化を調節するための組成物および方法
JP2009255576A Withdrawn JP2010063461A (ja) 1997-02-18 2009-11-06 細胞のNF−κB活性化を調節するための組成物および方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2009255576A Withdrawn JP2010063461A (ja) 1997-02-18 2009-11-06 細胞のNF−κB活性化を調節するための組成物および方法

Country Status (8)

Country Link
US (1) US5932425A (cg-RX-API-DMAC10.html)
EP (1) EP1009824B1 (cg-RX-API-DMAC10.html)
JP (2) JP4560616B2 (cg-RX-API-DMAC10.html)
AT (1) ATE391177T1 (cg-RX-API-DMAC10.html)
AU (1) AU6659198A (cg-RX-API-DMAC10.html)
CA (1) CA2281920C (cg-RX-API-DMAC10.html)
DE (1) DE69839326T2 (cg-RX-API-DMAC10.html)
WO (1) WO1998036070A1 (cg-RX-API-DMAC10.html)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2263835C (en) * 1996-08-26 2012-02-21 Signal Pharmaceuticals, Inc. Stimulus-inducible i (kappa)b kinase [ikk] signalsome
WO1998029101A1 (en) 1996-12-31 1998-07-09 Antioxidant Pharmaceuticals Corporation Pharmaceutical preparations of glutathione and methods of administration thereof
US6896899B2 (en) * 1996-12-31 2005-05-24 Antioxidant Pharmaceuticals Corp. Pharmaceutical preparations of glutathione and methods of administration thereof
CA2330210A1 (en) * 1998-06-13 1999-12-23 Zarpex Biosciences Limited Proteasomal activity
CN102816743A (zh) * 1998-12-10 2012-12-12 信号药物公司 调节NF-κB的人遍在蛋白连接酶E3
US6630312B2 (en) 1999-08-10 2003-10-07 Joslin Diabetes Center, Inc. Method for identifying compounds for treatment of insulin resistance
US6468755B1 (en) 1999-08-10 2002-10-22 Joslin Diabetes Center, Inc. Method for identifying compounds for treatment of insulin resistance
US20030104622A1 (en) * 1999-09-01 2003-06-05 Robbins Paul D. Identification of peptides that facilitate uptake and cytoplasmic and/or nuclear transport of proteins, DNA and viruses
FR2801902B1 (fr) * 1999-12-01 2005-03-04 Centre Nat Rech Scient Procedes de criblages fonctionnels d'agents aptes a moduler l'activite des complexes ubiquitine-ligases scf et leurs applications
WO2001079555A2 (en) 2000-04-14 2001-10-25 Millennium Pharmaceuticals, Inc. Roles of jak/stat family members in tolerance induction
US20030044852A1 (en) * 2000-08-10 2003-03-06 Joslin Diabetes Center, Inc., A Massachusetts Corporation Methods for treatment of insulin resistance
US20060287337A1 (en) * 2001-11-09 2006-12-21 Proteologics, Inc. Trans-golgi network-associated processes, methods and compositions related thereto
WO2003048202A2 (en) * 2001-12-03 2003-06-12 Asahi Kasei Pharma Corporation Nf-kappab activating genes
FR2859733A1 (fr) * 2003-09-15 2005-03-18 Centre Nat Rech Scient Procede de criblage fonctionnel d'agents aptes a moduler l'activite des ubiquitine hydrolases et leurs applications
US7393878B2 (en) * 2004-03-02 2008-07-01 The Procter & Gamble Company Method for curing high internal phase emulsions
FR2867783B1 (fr) * 2004-03-16 2008-02-01 Cytomics Systems Procede de criblage d'agent modulant l'ubiquitination de la proteine ikbalpha et moyens destines a la mise en oeuvre dudit procede
US20070060537A1 (en) * 2005-04-28 2007-03-15 Proteologics, Inc. Methods and compositions for inhibiting viral infections
US20100292306A1 (en) * 2005-05-24 2010-11-18 Carlson C George Compositions And Methods For The Treatment Of Muscular Dystrophy
US20070202593A1 (en) * 2006-02-27 2007-08-30 Research Development Foundation Cell-Targeted IKB and Methods for the Use Thereof
US20090182035A1 (en) * 2007-04-11 2009-07-16 Alcon Research, Ltd. Use of a combination of olopatadine and cilomilast to treat non-infectious rhinitis and allergic conjunctivitis
CA2682730A1 (en) * 2007-04-11 2008-10-23 Alcon Research, Ltd. Use of an inhibitor of tnf.alpha. plus an antihistamine to treat allergic rhinitis and allergic conjunctivitis
WO2010044892A1 (en) 2008-10-17 2010-04-22 President And Fellows Of Harvard College Diagnostic method based on large scale identification of post-translational modification of proteins
US20110082145A1 (en) * 2009-10-01 2011-04-07 Alcon Research, Ltd. Olopatadine compositions and uses thereof
CA3124670A1 (en) 2018-12-28 2020-07-02 Regeneron Pharmaceuticals, Inc. Treatment of respiratory disorders with arachidonate 15-lipoxygenase (alox15) inhibitors

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5122463A (en) * 1990-05-17 1992-06-16 Massachusetts Institute Of Technology Methods for trans-destabilization of specific proteins in vivo and dna molecules useful therefor
WO1994010307A1 (en) * 1992-10-29 1994-05-11 Medical Research Council Transcription factor dp-1
DE4243770A1 (de) * 1992-12-23 1994-06-30 Behringwerke Ag Verfahren zur Herstellung von rekombinanten und synthetischen Peptiden und deren Verwendung
IL114615A0 (en) * 1995-07-16 1995-11-27 Yeda Res & Dev Modulators of the function of fas receptors and other proteins
AU702844B2 (en) * 1995-06-23 1999-03-04 Tularik Inc. Interleukin-1 receptor-associated protein kinase and assays
CA2263835C (en) * 1996-08-26 2012-02-21 Signal Pharmaceuticals, Inc. Stimulus-inducible i (kappa)b kinase [ikk] signalsome

Similar Documents

Publication Publication Date Title
JP2002505631A5 (cg-RX-API-DMAC10.html)
JP2000509942A5 (cg-RX-API-DMAC10.html)
JP2000509637A5 (cg-RX-API-DMAC10.html)
JP2000510751A5 (cg-RX-API-DMAC10.html)
JP2000509912A5 (cg-RX-API-DMAC10.html)
JP2000509635A5 (cg-RX-API-DMAC10.html)
JP2000507042A5 (cg-RX-API-DMAC10.html)
JP2002505590A5 (cg-RX-API-DMAC10.html)
JP2001516213A5 (cg-RX-API-DMAC10.html)
JP2000509587A5 (cg-RX-API-DMAC10.html)
JP2000507369A5 (cg-RX-API-DMAC10.html)
JP2000507433A5 (cg-RX-API-DMAC10.html)
JP2000508866A5 (cg-RX-API-DMAC10.html)
JP2000510793A5 (cg-RX-API-DMAC10.html)
JP2000508022A5 (cg-RX-API-DMAC10.html)
JP2001520663A5 (cg-RX-API-DMAC10.html)
JP2000508841A5 (cg-RX-API-DMAC10.html)
JP2000508680A5 (cg-RX-API-DMAC10.html)
JP2000509804A5 (cg-RX-API-DMAC10.html)
JP2000509755A5 (cg-RX-API-DMAC10.html)
JP2000510969A5 (cg-RX-API-DMAC10.html)
JP2000510247A5 (cg-RX-API-DMAC10.html)
JP2000508102A5 (cg-RX-API-DMAC10.html)
JP2000509520A5 (cg-RX-API-DMAC10.html)
JP2000509818A5 (cg-RX-API-DMAC10.html)